P. hybridus Extract Ze 339 Inhibits RSV Infection by Altering Host Metabolism
Viruses · 24.06.2026 · 18 (7) · 697
DOI: 10.3390/v18070697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 24.06.2026. Verfasst von Fabian Otte und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, University of Basel, 4051 Basel, Switzerland. Hauptthemen laut MEDLINE: Antiviral Agents, Respiratory Syncytial Virus Infections, Plant Extracts, Respiratory Syncytial Virus, Human. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Max Zeller Söhne (Switzerland), Max Zeller Söhne AG.
Abstract (Originalsprache)
Respiratory syncytial virus (RSV) remains a major cause of severe respiratory disease worldwide, particularly affecting young children and immunocompromised individuals, highlighting the need for additional therapeutic strategies. In this study, the antiviral activity of the Petasites hybridus extract Ze 339 was investigated in RSV-infected cell-culture models. Antiviral efficacy was assessed using plaque reduction assays, reporter virus analyses, and proteomic profiling to elucidate potential mechanisms of action. Ze 339 potently reduced the infectivity of both RSVA and RSVB in vitro and retained antiviral activity when administered up to six hours post-infection, resulting in markedly reduced plaque formation and viral protein biosynthesis without inducing cytotoxicity. Proteomic analyses revealed that Ze 339 modulates host cell pathways associated with reduced cell proliferation, attenuated immune signaling, and enhanced cholesterol and lipid metabolism. These changes were more pronounced in infected than in uninfected cells and coincided with a marked downregulation of viral proteins. The observed proteomic signature suggests a host-directed antiviral effect and identifies altered lipid metabolism and cell-cycle-associated pathways as potential contributors to reduced RSV replication. Taken together, these findings demonstrate the antiviral activity of Ze 339 against RSV and support the hypothesis that modulation of host cell pathways contributes to its antiviral effects, providing a rationale for further evaluation of Ze 339 as a repurposed therapeutic candidate for RSV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedicine, University of Basel, 4051 Basel, Switzerland.
- Switzerland Medical Department, Max Zeller Söhne AG, 8590 Romanshorn, Switzerland.
ORCID-Profile: Thomas Klimkait, Veronika Butterweck, David Hauser
Förderung
- Max Zeller Söhne (Switzerland)
- Max Zeller Söhne AG
Zitieren
APA
Otte, F., Merk, V. M., Boonen, G., Klimkait, T., Butterweck, V., & Hauser, D. (2026). P. hybridus Extract Ze 339 Inhibits RSV Infection by Altering Host Metabolism. Viruses, 18(7), 697. https://doi.org/10.3390/v18070697
Vancouver
Otte F, Merk VM, Boonen G, Klimkait T, Butterweck V, Hauser D. P. hybridus Extract Ze 339 Inhibits RSV Infection by Altering Host Metabolism. Viruses. 2026;18(7):697. doi:10.3390/v18070697
BibTeX
@article{Otte2026,
author = {Otte, Fabian and Merk, Verena M and Boonen, Georg and Klimkait, Thomas and Butterweck, Veronika and Hauser, David},
title = {P. hybridus Extract Ze 339 Inhibits RSV Infection by Altering Host Metabolism},
journal = {Viruses},
year = {2026},
volume = {18},
number = {7},
pages = {697},
doi = {10.3390/v18070697}
}
EUVIMED